跳至主要内容
临床试验/NCT06491199
NCT06491199尚未招募不适用

HABPY: Home Assessment of Blood Pressure in PregnancY

University of British Columbia1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年7月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
Feasibility: recruitment rate of HBPT program

研究概览

简要总结

The goal of this observational study is to evaluate the feasibility and safety of a comprehensive home blood pressure telemonitoring (HBPT) program for pregnant people with hypertensive disorders of pregnancy (HDP).

Participants will receive training on the use of a home BP telemonitor with tele-transmission function for the remainder of their pregnancy and 6 weeks postpartum. Participating obstetric internal medicine (OBIM) clinicians will monitor the transmitted values and adjust anti-hypertensive medications based on the home BP readings.

Our primary goal is to describe the feasibility and safety of a comprehensive HBPT pilot program in British Columbia, Canada (BC).

Secondary research questions will address:

  1. What is the end-user acceptability of a comprehensive HBPT pilot program in BC?

  2. What are the effects of a comprehensive HBPT pilot program on factors such as:

  3. Maternal and neonatal outcomes 2. Home blood pressure (BP) metrics 3. Process measures 4. Anti-hypertensive medications 5. Fidelity to interventions 6. Health Care utilization

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult patients aged ≥ 19 years
  • Pregnancy
  • Gestational age 20+0 to 36+0 weeks gestational age
  • Diagnosed with gestational hypertension (defined as SBP ≥140 mm Hg and/or DBP ≥ 90 mm Hg) after 20 weeks gestation OR Chronic hypertension (defined as SBP ≥140 mm Hg and/or DBP ≥ 90 mm Hg), present at booking or before 20 weeks gestation, or receiving treatment (including lifestyle measures) prior to pregnancy and/or at time of referral OR Transient elevated office BP reading (defined as one time reading of SBP ≥140 mm Hg and/or DBP ≥ 90 mm Hg with risk factors for HDP as per Canadian guidelines).
  • Participant is willing and able to give informed consent for participation in the study
  • Able and willing to comply with study requirements
  • Has smart phone

排除标准

  • Anticipated inpatient admission
  • Remaining pregnancy less than 2 weeks duration
  • Imminent delivery (within the next 48 hours)
  • Non-English speaking or no family members who can help translate

结局指标

主要结局

Feasibility: recruitment rate of HBPT program

时间窗: From time of enrolment to 6 weeks post partum

Average number of participants who are screened and eligible who consent to participate in this study per month of recruitment.

Feasibility: retention rate of HBPT program

时间窗: From time of enrolment to 6 weeks post-partum

Rate of patients who are consented and enrolled in study and participate for the duration of the study period compared to those who are lost to follow-up or attrite during the study period.

Safety: Incidence density of study participants with severe hypertension

时间窗: From time of enrolment to 6 weeks post-partum.

Proportion of new cases of severe hypertension (defined as office/obstetrical visits/home systolic blood pressure (SBP) ≥ 160 mm Hg and/or diastolic blood pressure (DBP) ≥ 110 mm Hg) divided by the total person-time from enrolment to 6 weeks post-partum.

Safety: Proportion of participants with severe hypertension.

时间窗: From time of enrolment to 6 weeks post-partum

Number of patients who experience severe hypertension (defined as office/obstetrical visits/home systolic blood pressure (SBP) ≥ 160 mm Hg and/or diastolic blood pressure (DBP) ≥ 110 mm Hg) as a proportion of total study population.

次要结局

  • End-user acceptability of comprehensive HBPT program based on EuroQol 5 Dimension 5 Level(From time of enrolment to end of study period (6 weeks postpartum).)
  • End-user acceptability of comprehensive HBPT program based on Spielberger State-Trait Anxiety Inventory 6 (STAI-6) questionnaire.(From time of enrolment to end of study period (6 weeks postpartum).)
  • End-user acceptability of comprehensive HBPT program based on Patient Satisfaction Questionnaire Short Form (PSQ-18).(From time of enrolment to end of study period (6 weeks postpartum).)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karen Tran

Clinical Assistant Professor, General Internal Medicine

University of British Columbia

研究点 (1)

Loading locations...

相似试验